The Senior Directors team at ADMA Biologics is comprised of seasoned leaders overseeing critical functions like scientific research, data analysis, legal affairs, validation processes, regulatory compliance, business development, financial control, market access, quality assurance, and government health policy. Their collective expertise ensures the effective development, compliance, and commercialization of plasma-based biologics for infectious disease treatment and prevention.
Frank Sananes
Senior Director, Validation
James Maloney
Senior Director, Regulatory Af...
Jeffrey Gruenglas
Senior Director, Government Af...
Lucy Demario
Senior Director, Scientific & ...
Marc Gelberg
Corporate Controller
Michael Goldstein
Senior Director, General Couns...
Ricardo Carneiro
Senior Director, Market Access...
Skyler Bloom
Senior Director, Business Deve...
View all